Richard E. Wild, MD, JD, MBA, FACEP, has degrees in business and law and has practiced as a health-care attorney with a large Boston law firm representing hospitals, physicians, skilled nursing facilities, and a major Boston teaching hospital. He was medical director of Medicare’s direct fiscal intermediary in Baltimore and also the CMS (then HCFA) chief medical officer for reimbursement policy during the initial implementation of the Hospital Prospective Payment (DRG) system. He subsequently served on the Medicare Prospective Payment Assessment commission staff (now MEDPAC). He has also served as past president of the Rhode Island ACEP Chapter, alternate delegate to the Council, past national Chair of ACEP’s National Reimbursement Subcommittee of Government Affairs, and member national Government Affairs Committee and NEMPAC Board. Dr. Wild served a three-year term as ACEP’s representative to the AMA CPT-4 Editorial Advisory Board, was one of four ACEP representatives to the Harvard Relative Value study, and participated in ACEP’s national Coding and Nomenclature Committee. He is currently a member of the Georgia Chapter of ACEP and national ACEP. He has also been continuously certified by ABEM since 1985.
Explore This Issue
ACEP Now: Vol 33 – No 01 – January 2014Pages: 1 2 3 4 | Single Page
No Responses to “ED Waiting Room Posters on Prescribing Pain Medications May Violate EMTALA”